These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


392 related items for PubMed ID: 21900397

  • 1. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.
    Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, Lin J.
    Cancer Res; 2011 Dec 01; 71(23):7226-37. PubMed ID: 21900397
    [Abstract] [Full Text] [Related]

  • 2. STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.
    Lin L, Fuchs J, Li C, Olson V, Bekaii-Saab T, Lin J.
    Biochem Biophys Res Commun; 2011 Dec 16; 416(3-4):246-51. PubMed ID: 22074823
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
    Lin L, Hutzen B, Lee HF, Peng Z, Wang W, Zhao C, Lin HJ, Sun D, Li PK, Li C, Korkaya H, Wicha MS, Lin J.
    PLoS One; 2013 Dec 16; 8(12):e82821. PubMed ID: 24376586
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
    Han Z, Wang X, Ma L, Chen L, Xiao M, Huang L, Cao Y, Bai J, Ma D, Zhou J, Hong Z.
    Oncotarget; 2014 Sep 30; 5(18):8416-28. PubMed ID: 25261365
    [Abstract] [Full Text] [Related]

  • 5. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE.
    PLoS One; 2011 Sep 30; 6(6):e20636. PubMed ID: 21695188
    [Abstract] [Full Text] [Related]

  • 6. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS, Jeong YJ, Jeong SH, Heo HJ, Kim HK, Bae KB, Park YH, Kim SU, Kim JM, Kim N, Ko KS, Rhee BD, Han J.
    Gastroenterology; 2015 Oct 30; 149(4):1006-16.e9. PubMed ID: 26091938
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030.
    Lin L, Liu Y, Li H, Li PK, Fuchs J, Shibata H, Iwabuchi Y, Lin J.
    Br J Cancer; 2011 Jul 12; 105(2):212-20. PubMed ID: 21694723
    [Abstract] [Full Text] [Related]

  • 9. Ursolic acid inhibits the growth of colon cancer-initiating cells by targeting STAT3.
    Wang W, Zhao C, Jou D, Lü J, Zhang C, Lin L, Lin J.
    Anticancer Res; 2013 Oct 12; 33(10):4279-84. PubMed ID: 24122993
    [Abstract] [Full Text] [Related]

  • 10. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
    Leng Z, Tao K, Xia Q, Tan J, Yue Z, Chen J, Xi H, Li J, Zheng H.
    PLoS One; 2013 Oct 12; 8(2):e56082. PubMed ID: 23418515
    [Abstract] [Full Text] [Related]

  • 11. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
    Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ.
    Cancer Res; 2011 Jun 01; 71(11):3991-4001. PubMed ID: 21498635
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I, Liu S, Roh M, Vatan L, Szeliga W, Wei S, Banerjee M, Mao Y, Kotarski J, Wicha MS, Liu R, Zou W.
    Int J Cancer; 2012 Jan 01; 130(1):29-39. PubMed ID: 21480217
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
    Kumar Katakam S, Tria V, Sim WC, Yip GW, Molgora S, Karnavas T, Elghonaimy EA, Pelucchi P, Piscitelli E, Ibrahim SA, Zucchi I, Reinbold R, Greve B, Götte M.
    FEBS J; 2021 Jan 01; 288(2):486-506. PubMed ID: 32367652
    [Abstract] [Full Text] [Related]

  • 16. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
    Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY.
    Mol Cancer Res; 2008 Jul 01; 6(7):1146-53. PubMed ID: 18644979
    [Abstract] [Full Text] [Related]

  • 17. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.
    Shao C, Sullivan JP, Girard L, Augustyn A, Yenerall P, Rodriguez-Canales J, Liu H, Behrens C, Shay JW, Wistuba II, Minna JD.
    Clin Cancer Res; 2014 Aug 01; 20(15):4154-66. PubMed ID: 24907115
    [Abstract] [Full Text] [Related]

  • 18. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL, Pan F, Jiang H, Chen JF, Pei L, Xie FW, Liang HJ.
    Clin Exp Metastasis; 2011 Dec 01; 28(8):751-63. PubMed ID: 21750907
    [Abstract] [Full Text] [Related]

  • 19. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
    Lin L, Benson DM, DeAngelis S, Bakan CE, Li PK, Li C, Lin J.
    Int J Cancer; 2012 Mar 15; 130(6):1459-69. PubMed ID: 21520044
    [Abstract] [Full Text] [Related]

  • 20. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
    Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM.
    Cancer Res; 2009 Apr 15; 69(8):3382-9. PubMed ID: 19336570
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.